In last trading session, Liquidia Corp (NASDAQ:LQDA) saw 1.83 million shares changing hands with its beta currently measuring 0.13. Company’s recent per share price level of $19.30 trading at $0.65 or 3.49% at ring of the bell on the day assigns it a market valuation of $1.65B. That closing price of LQDA’s stock is at a premium of 2.12% from its 52-week high price of $18.89 and is indicating a premium of 57.2% from its 52-week low price of $8.26.

For Liquidia Corp (LQDA), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.20. Splitting up the data highlights that, out of 4 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 4 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.

Liquidia Corp (NASDAQ:LQDA) trade information

Upright in the green during last session for gaining 3.49%, in the last five days LQDA remained trading in the green while hitting it’s week-highest on Thursday, 05/15/25 when the stock touched $19.30 price level, adding 0.57% to its value on the day. Liquidia Corp’s shares saw a change of 64.12% in year-to-date performance and have moved 25.73% in past 5-day. Liquidia Corp (NASDAQ:LQDA) showed a performance of 41.91% in past 30-days.

Wall Street analysts have assigned a consensus price target of 27.5 to the stock, which implies a rise of 29.82% to its current value. Analysts have been projecting 19 as a low price target for the stock while placing it at a high target of 36. It follows that stock’s current price would jump 1.55% in reaching the projected high whereas dropping to the targeted low would mean a gain of 1.55% for stock’s current value.

Liquidia Corp (NASDAQ:LQDA)’s Major holders

CALIGAN PARTNERS LP is the top institutional holder at LQDA for having 10.36 million shares of worth $124.33 million. And as of 2024-06-30, it was holding 13.5551 of the company’s outstanding shares.

The second largest institutional holder is PATIENT SQUARE CAPITAL LP, which was holding about 7.18 million shares on 2024-06-30. The number of shares represents firm’s hold over 9.3968 of outstanding shares, having a total worth of $86.19 million.

On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024, the former fund manager was holding 1.99 shares of worth $38.44 million or 2.33% of the total outstanding shares. The later fund manager was in possession of 1.66 shares on Mar 31, 2025, making its stake of worth around $32.1 million in the company or a holder of 1.95% of company’s stock.